// App-Quantinova.ai

SP0163 (2018) : A case of severe osteoporosis and ischaemic heart disease; what will be the future cardiovascular risk?”

Researchers

Presenter

  • G. Weerasinghe

Principal Investigators

  • N/A

Medical Centers

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Musculoskeletal

  • Oncology (ONC)

  • Infectious Diseases (ID)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Vitamin D deficiency

  • Multiple Myeloma

  • Osteoporosis

  • Hypertension

  • Tuberculosis

  • Diabetes

Biomarkers

  • Alkaline phosphatase

  • Parathyroid Hormone

  • Creatinine

Drug/Treatment

  • Alkaline phosphatase

  • Alendronate sodium

  • Atorvastatin

  • Prednisolone

  • Bisoprolol

  • Omeprazole

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved